Normally Rab3A is predominantly expressed in the neural system; however, it has been found aberrantly overexpressed in breast cancer where it is associated with a more malignant phenotype and in hepatocellular carcinoma where, instead, it inhibits metastasis via enhancing mitochondrial oxidative metabolism [74]. The gene discussed is RAB3A; the disease is breast carcinoma.